PROVIDER PROFILE · NPI 1245230861
Peter BaeOD
PRESCRIBING · PART D · 2024
Total Rx claims
2,489
Beneficiaries
—
Total drug cost
$1.5M
Distinct drugs
14
Brand share
81.4%
Top prescribed drugs
Lifitegrast586 claims
Perfluorohexyloctane/Pf359 claims
Cyclosporine328 claims
Loteprednol Etabonate302 claims
Azelastine Hcl207 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE